Modi’s “One Earth, One Health” vision transforming pharma industry

Metro India News | Hyderabad 

India has long believed that health is a global responsibility. Prime Minister Narendra Modi has expressed this through the vision of “One Earth, One Health”. Over the last 12 years, the Indian pharmaceutical sector has grown from about US$ 20 billion to US$ 60 billion, while ensuring uninterrupted supply of medicines through the pandemic and recent geopolitical disruptions, including the West Asia crisis. It is expected to rise to $130 billion by 2030. This reflects the spirit of Vasudhaiva Kutumbakam, the world is one family.

India’s pharmaceutical exports have grown from US$ 14 billion in FY 2015 to US$ 31 billion in FY 2026, registering a compound annual growth rate of 7.22 percent. India is the third-largest producer of pharmaceuticals by volume, supplies around 20 percent of global generics demand, and exports to more than 200 countries. Recent initiatives such as Biopharma SHAKTI, with an outlay of Rs 10,000 crore over five years, will strengthen biologics, biosimilars, clinical trial infrastructure, NIPERs and more than 1,000 accredited clinical trial sites.

Pharma multinationals now run Global Capability Centres in India, employing more than 30,000 professionals and attracting over US$ 300 million in investment.  India will remain the Pharmacy of the World, become a laboratory of affordable innovation and serve as a reliable partner in global health security.